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ABSTRACT 
 
Background: Parkinson's disease is the most prevalent progressive neurological disease with motor 
deficits. The hallmark symptoms include bradykinesia, tremor, rigidity, and postural instability. The 
primary focus of physical therapy is to address these symptoms. The purpose of this case study is to 
present the use of the Lee Silverman Voice Treatment (LSVT)-BIG as a Parkinson's disorder 
intervention, along with a critical review of the literature. Case Description: The patient is a 71-year-old 
man diagnosed with Parkinson’s disease during the summer of 2019. Before any noticeable symptoms, 
the patient reported being active and independent without any self-reported limitations. The patient 
became progressively limited with overall mobility over a period of a year. The patient's primary 
complaints included poor standing and walking balance with a history of falls as well as difficulty 
performing activities of daily living. Intervention: The patient participated in LSVT-BIG that included 
daily exercises, patient-identified functional activities, and gait training. The program was four weeks in 
duration and consisted of four consecutive one-hour sessions each week. LSVT-BIG is amplitude-
based training with the cue for "big" as the sole focus. Outcome Measures: 10-Meter Walk Test, the 
Timed-Up and Go Test (with and without a cognitive task), the Functional Gait Assessment, and the 
Five Times Sit to Stand. Discussion: The patient made improvements in all outcome measures, 
demonstrating the potential benefits gained following the completion of LSVT-BIG. This case study 
provides additional research to the limited collection of evidence that currently exists for the support of 
LSVT-BIG. However, more high-quality randomized trials are needed to further assess the true efficacy 
of LSVT-BIG.  
 
Keywords:  Physical Therapy; rehabilitation; LSVT-BIG; Parkinson's Disease; parkinsonism; 
amplitude-based; exercise.  
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INTRODUCTION 
Parkinson's disease (PD), a progressive neurological condition, is considered the most 
prevalent disease with motor symptoms, and was originally described by James Parkinson in his 1817 
"Essay on the shaking palsy.” In this essay, the cardinal symptoms of PD are highlighted and included 
bradykinesia, tremor, and rigidity. Currently, postural instability is also considered a primary motor 
symptom of PD.1 These motor deficits are the characteristics of a parkinsonism presentation. Many 
conditions that do not have the pathological features of PD can present with such symptoms, however, 
PD is the most common.2  
The neuropathology of PD is the loss of dopaminergic neurons in the substantia nigra pars 
compacta located in the midbrain of the brain stem.  Another characteristic finding in PD is the 
accumulation of Lewy bodies, which are deposits that contain the protein alpha-synuclein.1 This 
pathological process is the underlying cause of motor dysfunction in patients with PD. However, non-
motor deficits are also present in PD, supporting the idea that other areas of the brain are also affected 
by neuronal degeneration.2 
In North America, the prevalence of PD is estimated that between 111 to 329 people per 
100,000. Similar estimates have been reported in Europe and South America.  Each year the incidence 
is roughly 10 to 18 per 100,000 people. Furthermore, both the incidence and the prevalence increase 
with age, peaking at approximately 80 years old, and by the year 2030 the prevalence of PD is 
estimated to increase by at least 50 percent.3  
The diagnosis of Parkinson’s is based on the criteria set by the PD brain bank of the United 
Kingdom. This set of criteria says that the patient must present with the following: slow initiation of 
movement, bradykinesia, and one other symptom (tremor, rigidity, or postural instability). It is important 
to note that by the time any motor symptoms become clinically present, 80 percent of dopaminergic 
neurons in the substantia nigra pars compacta have degenerated. The magnitude of this degeneration 
shows how severe the progression of the disease becomes before any clinical diagnosis, or most 
importantly, any treatment is provided. Additional requirements to diagnosis PD include the following: 
unilateral symptoms during onset, asymmetrical deficits, and the patient must respond well to dopamine 
replacement therapy.4 As mentioned previously, several other conditions can present with similar 
symptoms as PD but do not have the pathological features of PD.2 This highlights the importance of an 
extensive evaluation that must be conducted to rule out any other potential etiologies.  
More recently, additional testing using nuclear medicine tomographic imaging has become more 
common. The specific technique, called dopamine transporter (DAT) single-photon emission computed 
tomography (SPECT), looks at the concentration of DAT, which is highly associated with dopamine 
levels. DAT-SPECT imaging has demonstrated to be a useful tool for clinicians when evaluating for PD, 
however, the diagnosis should be based on the previously mentioned clinical criteria. This is important 
because such imaging does not differentiate between PD and other atypical degenerative Parkinsonism 
syndromes.5 In a systematic review by Suwijn et al. in 2015 that looked at the diagnostic accuracy of 
DAT-SPECT, it was concluded that this form of imaging could indeed be used to detect dopamine loss, 
however, additional research is needed due to the limited number of studies conducted.6  
Currently, there is no available treatment to stop the progressive neurodegeneration of the 
disease. The standard initial first-line treatment to manage symptoms of Parkinson's is levodopa, a 
dopaminergic prodrug. However, the duration of the drug's effectiveness begins to fade with the 
progression of the disease. This means the “on-off” symptoms become more frequent. During the "on" 
phase symptoms of levodopa, a patient may exhibit dyskinesias. Whereas during the "off" phase, the 
patient may revert back to the cardinal symptoms (bradykinesia, hypokinesis, rigidity, postural 
instability) of PD. To help manage such responses of levodopa, the addition of supplemental 
medications have shown to be beneficial.4 
Functional limitations for patients with PD not only come from the disease-causing motor 
impairments, but also from the secondary effects of deconditioning. This, combined with the natural 
progression of the disease as well as the adverse effects of levodopa, can have harsh effects on quality 
of life.7 On a positive note, evidence has shown that using exercise as an adjunct intervention can 
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improve cognitive abilities and motor control for patients with PD, minimizing functional loss.8 
Specifically, studies show that just short-term exercise programs can provide noticeable benefits for 
patients with PD.7 However, long-term exercise should be the goal so that functional mobility and 
health-related quality of life continue to improve.9  To emphasize long-term exercise, it has been shown 
that exercise programs of six or more months in duration have more significant improvements in 
dynamic balance and overall mobility when compared to short-term programs of two and even ten 
weeks.7 Additionally, patients with PD who exercise regularly, at least 2.5 hours per week for at least 
two years, have significantly better functional mobility and health-related quality of life versus patients 
who did not meet the 2.5-hour criteria for regular exercise.9 
Insufficient movement amplitude is the primary deficit that limits mobility in patients with PD. 
Addressing this deficit with external cues, by targeting the auditory, visual, or somatosensory systems, 
has shown to be beneficial.10 Refining motor performance in patients with PD is the goal when 
implementing such cues.8  It has been reported that these external cues trigger pathways that bypass 
the pathological areas of the brain, thus using the intact and so-called "healthy" nervous tissue.10 
These external cues are used during amplitude-based training, which is an intervention that 
focuses on improving movement amplitude to treat parkinsonism related motor symptoms. It was first 
introduced as a treatment option for patients with hypophonia secondary to PD and was called Lee 
Silverman Voice Treatment (LSVT)-LOUD. LSVT-LOUD is considered an evidence-based intervention 
to treat patients with PD related speech impairments, and research has shown that patients that 
participate in LSVT-LOUD retain improvements for at least two years.11 Another form of amplitude 
base-training is LSVT-BIG, which is derived from the LSVT-LOUD and focuses on improving the 
movement amplitude of patients with a parkinsonism disorder. It is an intensive program with the aim to 
recalibrate the patient's kinesthetic sense to normalize movement. LSVT-BIG is four weeks in duration 
with each week consisting of four consecutive one-hour treatment sessions.11 
In addition to LSVT-BIG, many other movement-based treatment options exist to address the 
functional deficits of individuals with PD. However, no treatment approach is considered the gold 
standard. The LSVT-BIG approach has gained popularity in recent years, yet only limited evidence 
supporting its effectiveness is available.  Thus, the purpose of this case study is to present the use of 
the LSVT-BIG as a Parkinson's disorder intervention, along with a critical review of the literature. 
 
CASE DESCRIPTION 
A 71-year-old man was diagnosed with a Parkinsonism disorder during the summer of 2018. 
DAT-SPECT imaging (described above) was performed approximately one year later with the results 
consistent of PD pathology. These results, in addition to the clinical presentation, confirmed a diagnosis 
of PD. However, no specific stage of PD was determined. The patient's other medical history included 
type 2 diabetes, hyperlipidemia, hypertension, hypercholesterolemia, functional urinary incontinence, 
prostate cancer, renal cell adenocarcinoma, and gastroesophageal reflux disease.   
Before any noticeable symptoms, the patient reported being active and independent without any 
self-reported limitations. However, over a period of a year, the patient became progressively limited 
with overall functional mobility. The patient's primary complaints included poor balance with standing 
and walking, and difficulty standing for periods greater than ten minutes because of feeling more off 
balance. Ultimately the patient’s balance deficits contributed to a history of falls. The patient also 
reported trouble standing up from a chair or toilet, getting up off the floor, and walking on an unstable 
surface. At baseline, the patient used a cane while ambulating indoors but required a walker for 
community distances. Other complicating factors include difficulty with memory and attention.  
The patient lived with his spouse in a multi-level house, thus requiring the patient to navigate 
stairs. Per the patient, stairs were a difficult task. The patient was retired and expressed that most of his 
physical activity occurred with the Silver Sneakers class at his local YMCA three times per week. The 
patient's goals for physical therapy were to improve his walking and overall mobility.  
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OBJECTIVE MEASURES  
During the initial evaluation, the Five Times Sit-to-Stand Test (FTSTS), the Timed Up and Go 
Test (TUG), the TUG with a dual cognitive task (TUG COG), the 10-Meter Walk Test (10MWT), and the 
Functional Gait Assessment (FGA) were all utilized to assess level of impairment and to track progress. 
All initial scores at evaluation can be seen in table one.  
The FTSTS was performed because the patient reported difficulty when standing up from a 
chair. This test has shown to have excellent reliability in PD.12 The patient's initial score was 38.5 
seconds, with scores greater than 16 seconds shown to be the cut-off score predictive of falls. 
Additionally, the TUG was performed to evaluate changes in sit to gait transfer. The TUG has 
also been reported to have excellent reliability in PD.13 The patient's first score at evaluation was 25.63 
seconds without an assistive device. This score was notably higher than the reported norm of eight 
seconds for the patient's age group, indicating a worse performance. The TUG COG was also 
performed to show the change in the patient's ability to perform functionally while simultaneously 
attending to a cognitive task. This test was conducted by asking the patient to count backward from 100 
by three. His evaluation score was 30.22, which was remarkably lower relative to the score of the TUG 
without a dual-task. Additionally, the patient performed this test without following full directions, 
counting backward by one instead of by three. This performance identified a potential cognitive deficit.  
Another test conducted and shown to have excellent reliability for patients with PD was the 
10MWT.14 This test was used to track how well his gait velocity improved following the LSVT BIG 
protocol. His initial walking speed at the evaluation was 0.36 meters per second.  
To test the patient's dynamic balance, the FGA was used. The patient's score at evaluation was 
9/30, putting him in the "at risk for falls" category. For patients with PD, the definition of this category is 
a score that is less than 15/30.15 This test also has excellent reliability for patients with PD.16   
When the patient's gait was analyzed, the patient demonstrated stereotypical slow gait speed, 
which stemmed from decreased stride length and foot clearance bilaterally as well as a limited arm 
swing. The patient also showed a forward and rounded posture and was not able to attend to functional 
activities during a simultaneous cognitive task. The patient's functional limitations included standing up 
from a low chair, walking household and community distances, and navigating crowded community 
environments. With the deficits and functional limitations in which the patient presented, as well as the 
patient's ability to respond well with amplitude-based cueing, it was determined that the patient would 
benefit from the LSVT BIG program. 
 
INTERVENTION 
Daily Protocol 
As previously mentioned, LSVT-BIG is a four-week long protocol with four consecutive days of 
one-hour sessions completed every week. Each visit consisted of three tasks and gait training. Task 
one consisted of the first two exercises of a daily exercise routine, and both exercises included 
sustained type movements in a seated position. Task two consisted of the remaining five exercises of 
the exercise routine. These five exercises were all in a standing position and performed with continuous 
movements instead of seated and sustained like the initial two exercises. The daily exercise routine is 
further detailed below.  
Task three consisted of functional movements that were identified by the patient. These 
movements were chosen at the beginning of the first session and were decided upon because he 
performed them routinely throughout day-to-day functions. It is important to note that sit-to-stand 
transfers was included as a functional movement to practice per the protocol. These functional 
movements were practiced every day with the patient performing five repetitions to start and 
progressing from there. 
Gait training, termed "big walking," was also performed daily and was done at the end of each 
session following task three. The cue was to "think big" with each step, and due to the patient’s limited 
attention, he was cued to focus on each lower extremity separately. It was important to not provide too 
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many instructions at once because of the patient’s limited attention. Thus, the lower extremities were 
the initial focus and the arm swing was incorporated during later sessions.  
 
Daily Exercises  
Before the start of the daily exercise routine, the patient and therapist sat down facing each 
other. This enabled the therapist to "model" the quality of movement that the patient attempted to 
mirror. A more in-depth description of each exercise is provided below.   
The initial position of the first two exercises was with the patient seated on the edge of the chair 
with full upright postural. The first exercise began with the patient pushing both of their hands out front 
of their body, followed with reaching down to the floor, then up overhead, and finally both upper 
extremities were brought down and back to approximately 90 degrees of shoulder abduction coupled 
with maximal horizontal adduction. This position was held for ten seconds. The exercise ended with a 
loud slap on the thigh with each hand. It is important to mention that each exercise was linked to 
pertinent functional movements specific to each patient. This helped demonstrate the saliency of each 
exercise.  
The second exercise was performed with one upper extremity at a time, started out by reaching 
out to the ipsilateral side then proceeded to reach across the body to the contralateral side, 
simultaneously rotating the hips toward the direction of reach. Ultimately, the patient and therapist 
sustained what looks like a modified lunge position for ten seconds. Again, the exercise ended with a 
loud slap with the extremity (that performed the reach) on the ipsilateral thigh. The patient performed all 
the repetitions on each side before the next exercise.  
Exercise three, the first of task two (standing exercises with continuous repetitions), began with 
the patient in a proper upright posture with his hands at his sides. The movement started with a "big" 
step forward with either his right or left lower extremity (mirroring the therapist) while he simultaneously 
reached both upper extremities out to the associated ipsilateral side. The patient proceeded by taking a 
step back so that all extremities were back to the starting position. After the assigned repetitions were 
completed, the same number of repetitions were then performed with the opposite lower extremity. 
Exercise four was similar to three, but rather than a forward step, a lateral step began the movement, 
followed with the patient having turned his head toward the direction of the step.  
Exercise five was performed with a step back to start. At this same moment, both upper 
extremities were simultaneously extended as far back as possible. This movement was coupled with 
trunk flexion, which looked like a form of “bowing down." When the assigned repetitions were 
completed, this exercise was then repeated with the opposite lower extremity.  
Exercise six was a form of simulated walking by utilizing arm swings and weight shifts. The 
starting position was with the patient's feet in a staggered placement, as if he had just taken a step and 
held that position. The exercise motion began with weight shifts back and forth between the front and 
back foot, which created a "rocking" type motion. Once the patient was able to get down this 
movement, full reciprocal arm swings were then incorporated so that both the lower and upper 
extremities were involved simultaneously.  
The last exercise, number seven, had the patient begin in a similar starting position as the 
previous standing exercises. The movement started with the patient reaching out laterally with both 
upper extremities (similar to exercise three and four) while simultaneously rotating at the trunk and hips. 
This rotation was either to the left or right (mirroring the therapist) but with the initial foot position 
maintained bilaterally. The goal was that each rotation was far enough so that the patient could see 
what is behind them. The movement was then finished with the patient rotating back to the initial 
position and with his hands back to his sides. 
 
Week 1  
On the first day of LSVT-BIG, the focus was on introducing the daily exercises to the patient, 
emphasizing basic form and moving "big" with full effort but without being highly critical of form. This 
required cueing for the majority of the time. However, the need for frequent cues was suspected due to 
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the novelty of each exercise. For task three, the functional component movements, the patient came up 
with the following to practice in the clinic: two steps into his house, donning his disposable underwear, 
getting in and out of a car, handwriting, and sit to stand from the toilet. Because of limited time, only sit-
to-stand transfers were practiced during this session. The patient was cued to perform a "big" reach 
prior to standing to shift his center of mass over his feet, easing the difficulty of the transfer. No "big" 
walking was performed on session one. Overall, the patient showed a good response to amplitude-
based training during the first session.  
With session two, the patient was able to demonstrate good carryover, showing a spontaneous 
"big" reach during sit to stand transfers. Even throughout the entire treatment session, the patient was 
able to continue performing sit to stand transfers with "big" mechanics and without any cues. However, 
during the daily exercises, the patient still required cueing for the majority of the time using verbal, 
visual, and tactile cues to get "bigger." Gait training was performed for the first time at the end of this 
session. During this training, the patient was instructed to take "big steps” with the goal of increasing 
stride length and foot clearance. 
Throughout sessions three and four, the patient continued to demonstrate recalibration by 
showing he could self-cue with sit to stand transfers using the "big reach" strategy that was taught in 
session one. His daily exercises still required cueing for the majority of the repetitions. "Big walking" 
also needed continuous cues to increase stride length and foot clearance. Additionally, verbal and 
visual cues for more significant arm swings were incorporated into gait training during this session. 
Specific to session four, the patient worked on dynamic balance by performing "monster walks" that 
allowed a slower type of gait to challenge balance. The patient's homework assigned following these 
two sessions was to "walk big" for the rest of the day.  
 
Week 2 
On the first day of week two (session five) of LSVT-BIG, the patient showed more noticeable 
improvements, demonstrated by the decrease in required cues during the daily tasks. During this 
session, the volume of the daily exercises was progressed, increasing the repetitions to the full ten. 
Despite this increase, the time it took to complete the daily exercises continued to be more and more 
efficient. Sit-to-stands were also progressed by decreasing the height of the sitting surface, challenging 
the patient to reach "bigger" to shift his weight more anteriorly over his feet, and to push harder with his 
lower extremities. The patient continued to demonstrate spontaneous "big" sit-to-stand transfers 
throughout the session, and the patient's wife also reported that he continued to perform "big" sit to-
stands at home. Despite the good spontaneous "bigness," standing from the toilet continued to be 
difficult, as reported by the patient's wife. For the patient's homework following this session, the patient 
focused on using a "big" effort later that coming night when getting up from the toilet.   
At the start of session six, the patient reported that he was feeling moderately fatigued, 
potentially due to just finishing a session of LSVT-LOUD, which will be discussed later. The patient also 
stated that he is compliant with his daily exercises at home but is frustrated by the amount of cueing he 
receives from his wife. Besides the patient report about feeling fatigued, nothing significant differed 
from session five. It is important to note that the patient complained of anterior knee pain after bouts of 
walking, requiring frequent rest breaks for relief. It is somewhat noticeable when the patient started to 
get this pain because the performance of his "big" walking began to fade due to his shift of focus from 
"big steps" to looking for a place to sit and rest. Overall, at this point in the protocol, the patient 
continued to progress, demonstrated by relatively less frequent cueing.  
Despite the progress, the patient showed poor attention throughout session seven, requiring 
relatively more cueing but also with limited response. This limited attention span was apparent since 
the start of the protocol. During gait training, this inattention deficit was addressed, educating the 
patient to maintain focus on "big" steps and to drown out any distractions. Also, during walking on this 
date, the patient continued to complain of anterior knee pain, stating, "I'm sore from all this walking."  
Reassessment was conducted during session eight, performing the same functional outcome 
measures that were completed during the initial evaluation. Before testing, the patient reported that he 
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thinks his "big" walking is becoming more automatic. Ultimately, this demonstrated the recalibration of 
the patient’s kinesthetic sense. Reassessment scores can be seen in table one.  
The reassessment scores, seen in table one, showed meaningful improvement following two 
weeks of LSVT-BIG. Reported minimal detectable change (MDC)13,14,16 was achieved with the TUG, 
gait velocity, and the FGA. Although there is currently no MDC or minimally clinically important 
difference (MCID) reported for the FTSTS or TUG COG in the PD population, the patient showed 
distinguishable improvements with these two tests. At this point, the patient also made notable 
advancement with car transfers, donning undergarments, navigating stairs, and handwriting. With gait 
training, the patient progressed with performance but was limited by endurance. As mentioned 
previously, when the patient became fatigued, his focus on large amplitude diminished which led to a 
regression in walking performance. 
 
FTSTS: Five-Times-Sit-To-Stand Test, TUG: Time Up and Go Test; MDC = 3.5,13 TUG COG: TUG with cognitive task, 
10MWT: 10-Meter Walk Test; MDC = 0.18,14 FGA: Functional Gait Assessment; expressed as absolute score out of 30;  
MDC = 4.16 * = Improvement by at least the reported Minimal Detectable Change (MDC) 
m/s = meters per second, s = second  
 
Week 3 
During session nine, the patient continued to require moderate to maximum cueing to maintain 
attention and large amplitude during daily exercises. The most significant progression to the patient's 
treatment was the increased walking distance to challenge the patient's endurance and focus. Fatigue 
and anterior knee pain were the two primary factors that continued to limit the patient's ability to 
perform continuous walking at relatively long distances. The patient's homework following the session 
was to walk "big" in small spaces due to the evident decrease in walking speed in such areas. This 
reduction was most noticeable when walking through doorways.  
Session ten's progression involved gait training in a more open environment with surroundings 
full of distractions, simulating community walking. During these distracting moments, the patient 
required maximum cueing to maintain a large amplitude. Additionally, the patient stated that he felt like 
he was moving "too big," which is a common complaint by patients. The therapist explained that when 
he moves with an amplitude that is "too big," other people see it as a normal movement. The therapist 
educated the patient that with a consistent large-amplitude, movements will start to feel normal. 
Another significant progression of this session was having the patient perform sit-to-stands from a low 
soft cushioned chair, simulating the patient's couch in his home. The patient was cued to "reach big" to 
shift his center of mass over his forefeet.  Because the patient demonstrated proper mechanics, the 
increase in difficulty was only minimal.  
With gait training during session eleven, the goal was to challenge the patient with an unsteady 
ground (walking on large airex), small spaces (walking through parallel bars), curb steps (box step), 
and obstacles (walking around cones). The patient was able to perform relatively well but still required 
max cueing to maintain a large amplitude due to the tendency of losing focus. No other progressions 
were made during this session. Session twelve was canceled. 
 
 
 
Test Initial Evaluation Reassessment Percent Change 
FTSTS 38.50s 21.78s 43 
TUG 25.63s *20.75s 19 
TUG COG 30.22s 28.25s 7 
10MWT 0.36m/s *0.74m/s 106 
FGA 9 *13 44 
Table 1. Functional outcome scores at initial evaluation and 2-week reassessment.   
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Week 4 
During task three of session thirteen, the patient and his wife expressed that practicing getting 
up off the floor would be beneficial due to concerns that he might fall and be unable to get up. The 
patient was able to perform with standby assist but required cues throughout for technique and to 
perform "big" movements. To make it a more step-by-step task, the therapist broke it down into several 
small tasks, simplifying the original complex movement for the patient. Additionally, the patient began to 
show spontaneous "big" gait throughout this session, demonstrating improved foot clearance and arm 
swing. With gait training, longer distances were continued in a more open environment and progressed 
to working on quick stops. With this progression, the patient required minimal assist to maintain 
balance.  
At the start of session fourteen, the patient reported having positive benefits from LSVT-BIG 
when asked about his thoughts on this program. During the treatment, the patient continued to 
demonstrate spontaneous "big" walking and sit-to-stand transfers. Gait training was again progressed, 
having the patient walk while performing a dual-task (balancing a ball on the open end of a cone) that 
simulated carrying a glass of water. The patient was then instructed to carry a glass of water at home 
for his homework. Getting up from the floor was again performed on this date with the patient showing 
carryover from the previous session, demonstrating the ability to complete the task without any cues.  
The primary focus of session fifteen was to continue working on quick stops and dual tasking 
with gait. The patient showed good performance, with continuous repetition being a contributing factor 
to the improvements of each task. There were no other significant progressions or highlights from this 
session.  
Session sixteen was the patient's last day of LSVT-BIG, with the plan to discharge following 
reassessment testing. Overall, these discharge reassessment scores (seen in table two) demonstrated 
meaningful improvement with sit to stand transfer and gait (velocity and balance). Additionally, the 
patient continued to make progress with all his patient-identified functional movements, requiring fewer 
cues. This progression suggested a recalibration occurred. Furthermore, as part of the discharge 
planning, the patient was educated on the commitment of LSVT-BIG beyond the four-week protocol 
because of the expectation to adapt to a new way of moving. To help maintain this adaptation, the 
patient continued with the daily exercise routine by performing each exercise one time each day. The 
plan was also to have the patient get periodic "checkups” to assess whether he was regressing, 
progressing, or maintaining the improvements he gained during the protocol. This would determine if he 
would benefit from a physical therapy "tune-up" or not. 
 
FTSTS: Five-Times-Sit-To-Stand Test, TUG: Time Up and Go Test; MDC = 3.5,13 TUG COG: TUG with cognitive task, 
10MWT: 10-Meter Walk Test; MDC = 0.18,14 FGA: Functional Gait Assessment; expressed as absolute score out of 30; MDC 
= 4.16 * = Improvement by at least the reported Minimal Detectable Change (MDC)  
m/s = meters per second, s = seconds 
 
LITERATURE REVIEW 
The focus of this literature review is to provide a summary of the most up to date evidence 
behind the efficacy of LSVT-BIG. The research described is of the highest quality available and most 
relevant to this case study. Other studies exist but only a limited amount compare LSVT-BIG to 
alternative forms of movement-based interventions.  
Test Initial Evaluation Discharge Percent Change 
5TSTS  38.50s 17.72s 54 
TUG 25.63s *18.31s 29 
TUG COG 30.22s 24.75s 18 
10MWT 0.36m/s  *0.96m/s 167 
FGA 9 *18 100 
Table 2. Functional outcome scores of 4-week reassessment and initial evaluation.   
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In a systematic review and meta-analysis conducted by McDonnell et al. in 2018,17 three 
randomized trials were analyzed to compare LSVT-BIG to alternate forms of exercise. General 
unsupervised exercise, Nordic Walking, and a similar shorter protocol to LSVT-BIG were all studied, 
using the motor function of the Unified Parkinson’s Disease Rating Scale (UPDRS-III) as the primary 
outcome of the meta-analysis performed. The results showed that patients had significantly more 
sustained benefit at three-months following completion of LSVT-BIG program versus Nordic walking, 
general unsupervised home exercise plan, or a shortened protocol. This provided some evidence 
behind the benefit of LSVT-BIG versus alternative interventions, however, the authors of this study 
determined that the included trials were only of moderate quality.17 
In a small study (n=9) conducted in 2017, gait speed, the Berg Balance Scale (BBS), FGA, 
quality of life (PDQ-39), and UPDRS-III were all analyzed in individuals diagnosed with stage one PD 
that participated in LSVT-BIG. In this study, all the subjects demonstrated improvements in at least one 
of the mentioned functional outcome measures following completion of LSVT-BIG.  Furthermore, the 
majority of patients sustained the improvements (improvements defined as the associated MCID of 
each measure) at a three-month follow-up. Additionally, at least half (5) of the participants reported an 
increase in quality of life which is defined as the MDC of the PDQ-39.18 
Additionally from 2017, a study with a similar set of outcomes also showed significant 
improvements in the FGA and BBS as well as the Six-Minute Walk Test, TUG, and TUG COG for 
individuals that participated in LSVT-BIG. This test also looked at the geriatric depression scale (GDC), 
which also showed improvement. It has been reported that this is a modified way to assess quality of 
life because the GDC includes a component of community participation.19 
Previous studies have reported that impaired functional mobility is exacerbated when 
performing a dual-task, thus compounding the limitations in community participation. However, in one of 
the largest LSVT-BIG efficacy studies conducted, dual-tasking ability in patients with PD was shown to 
improve. Specifically, this study showed significant improvements with mobility, with and without a dual-
task, following LSVT-BIG. This was demonstrated using the TUG for general mobility (without a dual-
task), and TUG COG (cognitive dual-task) and TUG MOTOR (motor dual-task) for mobility with a dual-
task. As previously stated, this study is one of the largest being addressed in this case study, reporting 
a sample size of 96. Additionally, no specific PD stage was indicated as part of the inclusion criteria 
making this study a relatively unique characteristic that aligns well with the patient of this case study.20 
For people with advanced progression of PD, medication will begin to have a wearing-off effect. 
This is when the window of effectiveness for dopamine replacement therapy starts to slowly lessen. 
The smaller window is evident when the patient begins to have more frequent dyskinesia fluctuations. 
Even with these types of patients, a small study (n=8) reported that patients with either stage two or 
three PD (and with at least two hours of “off-time” each day) were also able to benefit from the 
completion of LSVT-BIG, shown with improvements in the UPDRS-III.  Although the study showed 
good outcomes following completion of LSVT-BIG, these improvements did not continue beyond the 
protocol, thus suggesting and reiterating that unsupervised home exercise is not the most effective 
method for long-term outcomes. It should also be mentioned that this same study also looked at pre 
and post gait speeds and TUG scores with no significant improvement in either outcome.21  
Overall, the currently available research is highly limited. As previously outlined, most studies 
conducted have small sample sizes, no control group, and primarily only include patients with early 
stages of PD. These limitations make it challenging to get a true grasp of the efficacy of LSVT-BIG as a 
treatment for PD, especially for individuals with advanced stages. However, with what has been 
reported, it appears that patients will have some form of benefit following LSVT-BIG participation. It also 
seems that LSVT-BIG is a better intervention when compared to unsupervised home exercises alone. 
Although LSVT-BIG showed better improvements versus a shorter protocol and Nordic walking, it is 
difficult to determine whether LSVT-BIG is superior to other forms of supervised interventions due to 
the limited availability of literature that currently exists.  
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DISCUSSION  
The purpose of this case report was to present the application of LSVT-BIG in a physical 
therapy plan of care for a patient with PD. This type of treatment addressed the patient’s identified 
impairments that were initially outlined in the initial evaluation. These impairments included standing up 
from a low chair, walking household and community distances, and navigating crowded community 
environments. 
Following the initial evaluation, it was determined that the patient was an appropriate candidate 
for the LSVT-BIG program. This was concluded because it was evident that the patient could tolerate 
an intensive program and that the impairments and functional limitations that he presented with were 
able to be addressed using amplitude-based training.  
After the first two weeks of the program, the patient was able to show a meaningful 
improvement with the TUG, TUG COG, 10MWT, and the FGA, all demonstrating improved overall 
functional mobility. Most importantly, the patient continued to make substantial progress until the end of 
the four weeks. The increase in gait speed was the highlight of this case study, with the patient 
improving by 167 percent. This was the percent change between the 10MWT at the initial evaluation 
and the last day of the four-week protocol. Overall, the improvements the patient made were consistent 
with the outcomes of the research that was previously discussed.  
One of the unique characteristics of this case report is that this patient was going through LSVT-
LOUD during the same period as LSVT-BIG. This potentially may have contributed to the outcomes of 
this case study due to the additional reiteration of amplitude-based treatment. Another unique feature of 
this case study, and potentially a limitation, is that the patient was never diagnosed with a specific stage 
of PD. The severity of PD motor symptoms is typically categorized into several stages, which are based 
on the Modified Hoehn and Yahr Scale. Knowing this would have provided readers with a better sense 
of outcomes and prognosis with patients of the same Hoehn and Yahr stage. However, some readers 
may appreciate the uncertainty of this patient’s stage due to similar patient circumstances.  
Another potential limitation of this case report is that the UPDRS was not utilized as an outcome 
measure. It has been reported by the Neurological Section of the American Physical Therapy 
Association that this is the only outcome measure that is both highly recommended for all stages of PD 
and represents three ICF categories (body structure, activity, and participation). Additionally, being able 
to compare the outcomes of this case study has been somewhat limited due to the absence of the 
UPDRS as an outcome measure since this measure is commonly used in current literature.22  
 
CONCLUSION 
To conclude, this case report and literature review support the use of LSVT-BIG, a program that 
emphasizes exercise and amplitude-based training, as a treatment strategy to address the motor 
symptoms of PD.  Ultimately, this study outlines the potential benefits gained with improvements in 
overall functional mobility in patients with PD following the completion of LSVT-BIG. However, it must 
be noted that the results of this case study come from the patient described above and should not be 
extrapolated to all patients with PD. Not every patient will be appropriate for such an intense program, 
nor will all patients respond equally. This case study does, however, provide some additional evidence 
to the limited collection of research that currently exists for the support of LSVT-BIG. To further assess 
the true efficacy of LSVT-BIG, more randomized trials of higher quality are needed. 
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